Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Lluis Castells Fusté

Lluis Castells Fusté

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca
Lluis Castells Fusté

Lluis Castells Fusté

Lluis Castells Fusté

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca

Projects

Estudio de la quasiespecies del gen X en ARN circulante del virus de la hepatitis B (ARN-VHB): en búsqueda de nuevos factores pronósticos y dianas para terapia génica.

IP: -
Collaborators: Lluis Castells Fusté, Andrea Caballero Garralda, David Tabernero Caellas, Maria Francesca Cortese
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI18/01436
Duration: 01/01/2019 - 31/12/2022

DESARROLLO DE APLICACIONES DIAGNÓSTICAS EN INFECCION POR VHC BASADAS EN SECUENCIACIÓN DE MOLECULA ÚNICA EN TIEMPO REAL (SMRT-NNGS).

IP: Josep Quer Sivila
Collaborators: Lluis Castells Fusté, Silvia Sauleda Oliveras, Damir Garcia Cehic, Juan Ignacio Esteban Mur, Marta Bes Maijo, Cristina Dopazo Taboada
Funding agency: Instituto de Salud Carlos III
Funding: 153065
Reference: PI16/00337
Duration: 01/01/2017 - 31/05/2020

Búsqueda de posibles dianas terapéuticas en la región del gen x del virus de la hepatitis B en base al estudio de conservación de dicha región mediante secuenciación masiva.

IP: -
Collaborators: Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Maria del Pilar Reimundo Diaz-Fierros, Andrea Caballero Garralda
Funding agency: Instituto de Salud Carlos III
Funding: 110715
Reference: PI15/00856
Duration: 01/01/2016 - 30/06/2019

Malalties Hepatobiliars (GRC)

IP: -
Collaborators: Beatriz Minguez Rosique, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Antonio González Fernández, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Silvia Sauleda Oliveras, Maria Buti Ferret, Josep Quer Sivila, Josep Gregori Font, Maria Nieves Martell Pérez-Alcalde, Damir Garcia Cehic, Juan Ignacio Esteban Mur, Meritxell Ventura Cots, Macarena Simon-Talero Horga, Joan Genescà Ferrer, David Tabernero Caellas
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 65000
Reference: 2014 SGR 421
Duration: 01/01/2014 - 31/12/2016

Related news

La Dra. Itxarone Bilbao

Vall d’Hebron participates in a consensus to optimize equity in access to liver transplant

The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.

Dr. Raul Herance

We develop a method to diagnose fatty liver in a quantitative and non-invasive way

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Pacient d'un assaig clínic a la consulta

VHIR exceeds 700 active clinical trials to achieve new therapies for patients

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

See more

Related professionals

Jaume Alijotas Reig

Jaume Alijotas Reig

Head of group
Systemic Diseases
Read more
Guillem Pons Barcons

Guillem Pons Barcons

Postdoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Javier Sánchez López

Javier Sánchez López

Research technician
Research Group on Status Epilepticus and Acute Seizures
Read more
Rafael Simó Canonge

Rafael Simó Canonge

Head of group
Diabetes and Metabolism
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.